Return On Assets of Lipocine Inc. from 30 Jun 2013 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lipocine Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2013 to 30 Sep 2025.
  • Lipocine Inc. Return On Assets for the quarter ending 30 Sep 2025 was -28%, a 60% decline year-over-year.
  • Lipocine Inc. annual Return On Assets for 2024 was 0.04%.
  • Lipocine Inc. annual Return On Assets for 2023 was -58%, a 126% decline from 2022.
  • Lipocine Inc. annual Return On Assets for 2022 was -26%, a 1838% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Lipocine Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -28% -11% -60% 01 Jul 2025 30 Sep 2025
Q2 2025 -22% +13% +38% 01 Apr 2025 30 Jun 2025
Q1 2025 -25% +9.8% +28% 01 Jan 2025 31 Mar 2025
Q4 2024 0.04% +58% 01 Oct 2024 31 Dec 2024
Q3 2024 -18% +34% +66% 01 Jul 2024 30 Sep 2024
Q2 2024 -35% -1.2% -3.5% 01 Apr 2024 30 Jun 2024
Q1 2024 -35% -5.5% -19% 01 Jan 2024 31 Mar 2024
Q4 2023 -58% -32% -126% 01 Oct 2023 31 Dec 2023
Q3 2023 -51% -60% -670% 01 Jul 2023 30 Sep 2023
Q2 2023 -34% -42% -555% 01 Apr 2023 30 Jun 2023
Q1 2023 -29% -27% -1710% 01 Jan 2023 31 Mar 2023
Q4 2022 -26% -24% -1838% 01 Oct 2022 31 Dec 2022
Q3 2022 9% +52% 01 Jul 2022 30 Sep 2022
Q2 2022 7.5% +59% 01 Apr 2022 30 Jun 2022
Q1 2022 -1.6% +58% +97% 01 Jan 2022 31 Mar 2022
Q4 2021 -1.3% +87% +98% 01 Oct 2021 31 Dec 2021
Q3 2021 -43% +45% +51% 01 Jul 2021 30 Sep 2021
Q2 2021 -51% +39% +43% 01 Apr 2021 30 Jun 2021
Q1 2021 -60% +20% +25% 01 Jan 2021 31 Mar 2021
Q4 2020 -89% -23% -36% 01 Oct 2020 31 Dec 2020
Q3 2020 -89% -25% -39% 01 Jul 2020 30 Sep 2020
Q2 2020 -91% -34% -59% 01 Apr 2020 30 Jun 2020
Q1 2020 -80% -27% -51% 01 Jan 2020 31 Mar 2020
Q4 2019 -65% -19% -41% 01 Oct 2019 31 Dec 2019
Q3 2019 -64% -12% -22% 01 Jul 2019 30 Sep 2019
Q2 2019 -57% +1.7% +2.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -53% +15% +22% 01 Jan 2019 31 Mar 2019
Q4 2018 -46% +32% +41% 01 Oct 2018 31 Dec 2018
Q3 2018 -52% +16% +23% 01 Jul 2018 30 Sep 2018
Q2 2018 -59% +2.2% +3.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -68% -10% -18% 01 Jan 2018 31 Mar 2018
Q4 2017 -79% -20% -34% 01 Oct 2017 31 Dec 2017
Q3 2017 -68% -12% -22% 01 Jul 2017 30 Sep 2017
Q2 2017 -61% -3.8% -6.7% 01 Apr 2017 30 Jun 2017
Q1 2017 -57% -9.5% -20% 01 Jan 2017 31 Mar 2017
Q4 2016 -59% -17% -39% 01 Oct 2016 31 Dec 2016
Q3 2016 -56% -11% -24% 01 Jul 2016 30 Sep 2016
Q2 2016 -57% -13% -30% 01 Apr 2016 30 Jun 2016
Q1 2016 -48% +12% +20% 01 Jan 2016 31 Mar 2016
Q4 2015 -42% +17% +29% 01 Oct 2015 31 Dec 2015
Q3 2015 -45% +7.9% +15% 01 Jul 2015 30 Sep 2015
Q2 2015 -44% +5.8% +12% 01 Apr 2015 30 Jun 2015
Q1 2015 -60% -14% -29% 01 Jan 2015 31 Mar 2015
Q4 2014 -59% -8.4% -16% 01 Oct 2014 31 Dec 2014
Q3 2014 -53% -42% -383% 01 Jul 2014 30 Sep 2014
Q2 2014 -50% -142% -154% 01 Apr 2014 30 Jun 2014
Q1 2014 -46% 01 Jan 2014 31 Mar 2014
Q4 2013 -51% 01 Oct 2013 31 Dec 2013
Q3 2013 -11% 01 Jul 2013 30 Sep 2013
Q2 2013 92% 01 Apr 2013 30 Jun 2013

Lipocine Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 0.04% +58% 01 Jan 2024 31 Dec 2024
2023 -58% -32% -126% 01 Jan 2023 31 Dec 2023
2022 -26% -24% -1838% 01 Jan 2022 31 Dec 2022
2021 -1.3% +87% +98% 01 Jan 2021 31 Dec 2021
2020 -89% -23% -36% 01 Jan 2020 31 Dec 2020
2019 -65% -19% -41% 01 Jan 2019 31 Dec 2019
2018 -46% +32% +41% 01 Jan 2018 31 Dec 2018
2017 -79% -20% -34% 01 Jan 2017 31 Dec 2017
2016 -59% -17% -39% 01 Jan 2016 31 Dec 2016
2015 -42% +17% +29% 01 Jan 2015 31 Dec 2015
2014 -59% -8.4% -16% 01 Jan 2014 31 Dec 2014
2013 -51% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.